SIERRA ONCOLOGY : Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737

Press/Media: Press / Media

PeriodNov 29 2018

Media coverage

1

Media coverage

  • TitleSIERRA ONCOLOGY : Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletMarketScreener.com
    CountryUnited States
    Date11/29/18
    PersonsJing Wang